{"id":"4d1e3597-94fd-49fc-a8fd-ab996fe80708","kind":"news","code":"4d1e3597-94fd-49fc-a8fd-ab996fe80708","name":"Yuanmazhiyao raises tens of millions of RMB in Pre-Series A financing","nameBasis":"translated-title","summary":"On 2026-07-22, according to Xiniu Data, Yuanmazhiyao completed Pre-Series A financing, raising tens of millions of RMB. Investors were Yifeng Capital, Yingxi Intelligence and others. The company is a developer of circular mRNA-based in vivo CAR-T therapies.","description":"","country":null,"category":null,"originalName":"元码智药完成Pre-A轮融资，金额数千万人民币","eventDate":"2026-07-22T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:17.433Z","englishUpdatedAt":"2026-10-20T18:31:05.551Z","reviewedAt":"2026-10-20T18:31:05.551Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"5489b78ea7ad449a84aebf4529c26df67c09cd6588585f7333630808d7550f1f","companyId":"d8b9bfd5-1e23-4188-84ec-0527f602ddbc","foundedYear":null,"logoUrl":null,"originalText":"2026年7月22日，据烯牛数据报道，元码智药完成Pre-A轮融资，金额数千万人民币。投资方为倚锋资本，英矽智能等。该公司为环状mRNA体内CAR‑T疗法研发商。","sources":[],"related":[{"id":"ae97b918-b334-4df8-acac-c59c2994300a","kind":"institutions","code":"UB-I7305","name":"Yifeng Capital","nameBasis":"transliterated","summary":"Yifeng Capital, a healthcare-focused venture capital firm.","description":"Yifeng Capital, a healthcare-focused venture capital firm.","country":null,"category":null,"originalName":"倚锋资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.523Z","englishUpdatedAt":"2026-10-16T01:39:37.876Z","reviewedAt":"2026-10-16T01:39:37.876Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"b51b7c327267c7251e94de6c50496a8c1267cc2c044c701435ac057a6b1088fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/UB-I7305"},{"id":"62b717d6-1573-48ec-8315-cbd417de1f2b","kind":"institutions","code":"UB-I8385","name":"Yingxi Intelligence","nameBasis":"transliterated","summary":"Yingxi Intelligence, an investment entity undertaking strategic investments.","description":"Yingxi Intelligence, an investment entity undertaking strategic investments.","country":null,"category":null,"originalName":"英矽智能","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:26:18.054Z","englishUpdatedAt":"2026-10-15T17:35:39.114Z","reviewedAt":"2026-10-15T17:35:39.114Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"259cd55ef6f013ccfeb4cc36895d0e45ded8d507ef1a446cfac3893fc5e3a7c6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/yingxi-intelligence"},{"id":"d8b9bfd5-1e23-4188-84ec-0527f602ddbc","kind":"companies","code":"UB-C10450","name":"Yuanmazhiyao","nameBasis":"transliterated","summary":"Developer of circular mRNA-based in vivo CAR-T therapies.","description":"Developer of circular mRNA-based in vivo CAR-T therapies.","country":"China","category":null,"originalName":"元码智药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:36.679Z","reviewedAt":"2026-10-20T18:26:36.679Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"9e1300c93c1b3bdae50a7f95f15f33e6e239d31f6d6ae9cd06cc4835f3e969ad","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C10450"}],"path":"/news/4d1e3597-94fd-49fc-a8fd-ab996fe80708","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Yuanmazhiyao","path":"/companies/UB-C10450"}},"canonical":"https://uniquebase.ai/news/4d1e3597-94fd-49fc-a8fd-ab996fe80708"}